T2 Biosystems, Prxcision to Market Diagnostic Solutions for Bloodstream Infections, Antibiotic Resistance

MT Newswires Live10-09

T2 Biosystems (TTOO) and Prxcision said Tuesday they will comarket diagnostic solutions to identify suspected bloodstream infections and sepsis, and tackle the growing issue of antibiotic resistance.

T2 Biosystems' fast blood tests, combined with Prxcision's AI platform, will provide quick identification of pathogens "in hours, not days," and insights to care providers.

The collaboration is expected to boost product adoption improve outcomes and reduce costs related to antimicrobial resistance and sepsis management, according to a joint statement.

T2 Biosystems shares were up 1% in recent trading.

Price: 1.65, Change: +0.02, Percent Change: +1.23

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2474408026?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-09 00:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474408026","market":"hk","top_or_hot":-1,"title":"T2 Biosystems, Prxcision to Market Diagnostic Solutions for Bloodstream Infections, Antibiotic Resistance","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/TTOO\">T2 Biosystems</a> (TTOO) and Prxcision said Tuesday they will comarket diagnostic solutions to identify suspected bloodstream infections and sepsis, and tackle the growing issue of antibiotic resistance.</p><p>T2 Biosystems' fast blood tests, combined with Prxcision's AI platform, will provide quick identification of pathogens \"in hours, not days,\" and insights to care providers.</p><p>The collaboration is expected to boost product adoption improve outcomes and reduce costs related to antimicrobial resistance and sepsis management, according to a joint statement.</p><p>T2 Biosystems shares were up 1% in recent trading.</p><p>Price: 1.65, Change: +0.02, Percent Change: +1.23</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>T2 Biosystems, Prxcision to Market Diagnostic Solutions for Bloodstream Infections, Antibiotic Resistance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nT2 Biosystems, Prxcision to Market Diagnostic Solutions for Bloodstream Infections, Antibiotic Resistance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-09 00:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>T2 Biosystems (TTOO) and Prxcision said Tuesday they will comarket diagnostic solutions to identify suspected bloodstream infections and sepsis, and tackle the growing issue of antibiotic resistance....</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2474408026","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474408026","pubTimestamp":1728405366,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"T2 Biosystems  and Prxcision said Tuesday they will comarket diagnostic solutions to identify suspected bloodstream infections and sepsis, and tackle the growing issue of antibiotic resistance.T2 Biosystems' fast blood tests, combined with Prxcision's AI platform, will provide quick identification of pathogens \"in hours, not days,\" and insights to care providers.The collaboration is expected to boost product adoption improve outcomes and reduce costs related to antimicrobial resistance and sepsis management, according to a joint statement.T2 Biosystems shares were up 1% in recent trading.Price: 1.65, Change: +0.02, Percent Change: +1.23","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4583":"猴痘概念","TTOO":"T2 Biosystems"},"translate_title":"T2 Biosystems，Prxcision将推出针对血流感染、抗生素耐药性的诊断解决方案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TTOO":1},"content_text":"T2 Biosystems (TTOO) and Prxcision said Tuesday they will comarket diagnostic solutions to identify suspected bloodstream infections and sepsis, and tackle the growing issue of antibiotic resistance.T2 Biosystems' fast blood tests, combined with Prxcision's AI platform, will provide quick identification of pathogens \"in hours, not days,\" and insights to care providers.The collaboration is expected to boost product adoption improve outcomes and reduce costs related to antimicrobial resistance and sepsis management, according to a joint statement.T2 Biosystems shares were up 1% in recent trading.Price: 1.65, Change: +0.02, Percent Change: +1.23","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2474408026"}